Decathlon Capital’s Revenue Based

Financing Portfolio In the News

Nine Decathlon Capital Portfolio Companies Make the Inc. 5000

Decathlon Capital’s revenue-based financing solutions help companies accelerate growth and create value without any dilution or loss of control, so we’re proud to announce that nine of our portfolio companies have made this year’s prestigious Inc. 5000 list of the fastest-growing private companies in the United States. 

read more

ImQuest Aquired by Cytocom

Cytocom acquires ImQuest JULY 20, 2020 FLORIDA, USA-based private clinical-stage biopharma Cytocom today announced the acquisition of ImQuest Life Sciences, a research and development company focused specifically on cancer, inflammation and infectious disease...

read more

NowRx raised $20 million to Expediate Prescription Deliveries

NowRx raises $20 million to expedite prescription deliveries with automation July 15, 2020 Pharmaceutical startup NowRx today announced it has closed a $20 million round raised through crowdfunding platform SeedInvest. NowRx, which claims the round is the largest in...

read more

ENGAGE

If you are looking for capital to accelerate your growth, we would love to talk.

Join our newsletter to stay up to date on announcements

SALT LAKE CITY

 

1441 West Ute Blvd. Suite 240

Park City, UT 84098

435.200.1051
[email protected]

 

 SAN FRANCISCO

 

300 Hamilton Ave, Suite 400

Palo Alto, CA. 94301

650.468.2972
[email protected]